| Dr Laurie Ann Womack, DNP, PMHNP | |
|
1615 Delaware St, Longview, WA 98632-2367 | |
| (360) 414-2000 | |
| Not Available |
| Full Name | Dr Laurie Ann Womack |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 1615 Delaware St, Longview, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801300165 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Peacehealth St John Medical Center | Longview, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Telecare Mental Health Services Of Washington, Inc | 5698804409 | 12 |
| Peacehealth | 5890689293 | 182 |
News Archive
Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced that on December 22, 2009, it completed its registered direct offering with institutional investors, raising an aggregate amount of approximately $7.5 million of gross proceeds (before placement agent fees and offering expenses) through the sale of 3,747,558 units.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the European Medicines Agency (EMA) granted orphan product designation for SBC-102 (Recombinant Human Lysosomal Acid Lipase), the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase (LAL) Deficiency.
RegeneRx Biopharmaceuticals, Inc. has announced that thymosin beta 4 (Tβ4) can activate a unique subpopulation of resident adult epicardial stem cells such that they recapture embryonic potential, proliferate, migrate and differentiate into functional heart muscle (cardiomyocytes), according to a research paper published online today in Nature.
The case of a Chinese man nearly 80 years old who was recently diagnosed with HIV is "shedding light on a segment of the Chinese population said to be overlooked by the country's AIDS education efforts," according to "a recent report from state-run media Xinhua News Agency," the Wall Street Journal's "China Real Time" blog reports.
› Verified 1 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720056187 PECOS PAC ID: 5890689293 Enrollment ID: O20040209000272 |
News Archive
Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced that on December 22, 2009, it completed its registered direct offering with institutional investors, raising an aggregate amount of approximately $7.5 million of gross proceeds (before placement agent fees and offering expenses) through the sale of 3,747,558 units.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the European Medicines Agency (EMA) granted orphan product designation for SBC-102 (Recombinant Human Lysosomal Acid Lipase), the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase (LAL) Deficiency.
RegeneRx Biopharmaceuticals, Inc. has announced that thymosin beta 4 (Tβ4) can activate a unique subpopulation of resident adult epicardial stem cells such that they recapture embryonic potential, proliferate, migrate and differentiate into functional heart muscle (cardiomyocytes), according to a research paper published online today in Nature.
The case of a Chinese man nearly 80 years old who was recently diagnosed with HIV is "shedding light on a segment of the Chinese population said to be overlooked by the country's AIDS education efforts," according to "a recent report from state-run media Xinhua News Agency," the Wall Street Journal's "China Real Time" blog reports.
› Verified 1 days ago
| Entity Name | Telecare Mental Health Services Of Washington, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780913657 PECOS PAC ID: 5698804409 Enrollment ID: O20100603000217 |
News Archive
Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced that on December 22, 2009, it completed its registered direct offering with institutional investors, raising an aggregate amount of approximately $7.5 million of gross proceeds (before placement agent fees and offering expenses) through the sale of 3,747,558 units.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the European Medicines Agency (EMA) granted orphan product designation for SBC-102 (Recombinant Human Lysosomal Acid Lipase), the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase (LAL) Deficiency.
RegeneRx Biopharmaceuticals, Inc. has announced that thymosin beta 4 (Tβ4) can activate a unique subpopulation of resident adult epicardial stem cells such that they recapture embryonic potential, proliferate, migrate and differentiate into functional heart muscle (cardiomyocytes), according to a research paper published online today in Nature.
The case of a Chinese man nearly 80 years old who was recently diagnosed with HIV is "shedding light on a segment of the Chinese population said to be overlooked by the country's AIDS education efforts," according to "a recent report from state-run media Xinhua News Agency," the Wall Street Journal's "China Real Time" blog reports.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laurie Ann Womack, DNP, PMHNP 332 King Rd, Silverlake, WA 98645-9718 Ph: (360) 431-1940 | Dr Laurie Ann Womack, DNP, PMHNP 1615 Delaware St, Longview, WA 98632-2367 Ph: (360) 414-2000 |
News Archive
Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced that on December 22, 2009, it completed its registered direct offering with institutional investors, raising an aggregate amount of approximately $7.5 million of gross proceeds (before placement agent fees and offering expenses) through the sale of 3,747,558 units.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the European Medicines Agency (EMA) granted orphan product designation for SBC-102 (Recombinant Human Lysosomal Acid Lipase), the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase (LAL) Deficiency.
RegeneRx Biopharmaceuticals, Inc. has announced that thymosin beta 4 (Tβ4) can activate a unique subpopulation of resident adult epicardial stem cells such that they recapture embryonic potential, proliferate, migrate and differentiate into functional heart muscle (cardiomyocytes), according to a research paper published online today in Nature.
The case of a Chinese man nearly 80 years old who was recently diagnosed with HIV is "shedding light on a segment of the Chinese population said to be overlooked by the country's AIDS education efforts," according to "a recent report from state-run media Xinhua News Agency," the Wall Street Journal's "China Real Time" blog reports.
› Verified 1 days ago